DAILYZ HEALTH NEWS

March 15, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

March 15, 2024 Evan Vega

WeightWatchers CEO just sent a memo to employees as stock crashes

Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani has sent an internal

Behind the scenes, healthcare workers are battling burnout

Neurological

March 15, 2024 Evan Vega

Compassion Fatigue: What to Do When Care Becomes Overwhelming

In the demanding and emotionally-charged field of health care, physicians often find themselves at the forefront of providing care and

Public Health

March 15, 2024 Evan Vega

Joe Biden’s Skittish Support for Abortion Rights

President Biden spent much of his State of the Union speech last week talking about two subjects central to his

Public Health

March 15, 2024 Evan Vega

How Your In-Network Health Coverage Can Vanish Before You Know It

Sarah Feldman, 35, received the first ominous letters from Mount Sinai Medical last November. The New York hospital system warned

Public Health

March 15, 2024 Evan Vega

A New Orleans Neighborhood Confronts the Racist Legacy of a Toxic Stretch of Highway

Aside from a few discarded hypodermic needles on the ground, the Hunter’s Field Playground in New Orleans looks almost untouched.

Public Health

March 15, 2024 Evan Vega

When Copay Assistance Backfires on Patients

In early 2019, Jennifer Hepworth and her husband were stunned by a large bill they unexpectedly received for their daughter’s

Infectious Disease

March 15, 2024 Evan Vega

HIV study demonstrates potential of long-acting ART in Africa

March 14, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

FDA approves NASH liver disease drug from Madrigal Pharmaceuticals

Public Health

March 15, 2024 Evan Vega

FDA approves NASH liver disease drug from Madrigal Pharmaceuticals

In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images |

Infectious Disease

March 14, 2024 Evan Vega

Significant number of US teens report delta-8 THC use

March 14, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

FDA Approves Blood Test for Early Alzheimer’s Risk Detection Using Neutrophil Inflammation Marker

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

FDA Approves Blood Test for Early Alzheimer’s Risk Detection Using Neutrophil Inflammation Marker

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

FDA Approves Blood Test for Early Alzheimer’s Risk Detection Using Neutrophil Inflammation Marker

National HIV self-testing program finds high demand, many testing for first time

WeightWatchers CEO just sent a memo to employees as stock crashes

Compassion Fatigue: What to Do When Care Becomes Overwhelming

Joe Biden’s Skittish Support for Abortion Rights

How Your In-Network Health Coverage Can Vanish Before You Know It

A New Orleans Neighborhood Confronts the Racist Legacy of a Toxic Stretch of Highway

When Copay Assistance Backfires on Patients

HIV study demonstrates potential of long-acting ART in Africa

FDA approves NASH liver disease drug from Madrigal Pharmaceuticals

Significant number of US teens report delta-8 THC use